Cargando…
Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that may cause severe bleeding complications with risk of perinatal death or lifelong disability. The main cause of FNAIT is maternal antibodies against human platelet antigen (HPA)-1a. Both fetomaternal bleeding and transplacental...
Autores principales: | Kjær, Mette, Tiller, Heidi, Heide, Gøril, Kjeldsen-Kragh, Jens, Skogen, Bjørn, Husebekk, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570354/ https://www.ncbi.nlm.nih.gov/pubmed/28837581 http://dx.doi.org/10.1371/journal.pone.0182957 |
Ejemplares similares
-
Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model
por: Eksteen, Mariana, et al.
Publicado: (2017) -
The Development of Severe Neonatal Alloimmune Thrombocytopenia due to Anti-HPA-1a Antibodies Is Correlated to Maternal ABO Genotypes
por: Ahlen, Maria Therese, et al.
Publicado: (2012) -
Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
por: Weng, Ying-Jan, et al.
Publicado: (2016) -
Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities
por: Tiller, Heidi, et al.
Publicado: (2017) -
Pregnant Women at Low Risk of Having a Child with Fetal and Neonatal Alloimmune Thrombocytopenia Do Not Require Treatment with Intravenous Immunoglobulin
por: Kjeldsen-Kragh, Jens, et al.
Publicado: (2023)